Skip to main content

Lung Cancer: Not Just a Man's Killer

Lung cancer has long been associated as a killer of men but now it has passed breast cancer as the number one killing cancer of women. The American Cancer Society states that women are 1.5 times more likely to get lung cancer than men. Studies also show that African American women are more likely to get lung cancer than white women.

While smoking is a leading cause of lung cancer to smokers, secondhand smoke also causes lung cancer and coronary heart disease to nonsmokers. There are about 20% of the women diagnosed with lung cancer who have never smoked (American Cancer Society). Some factors besides secondhand smoke includes: exposure to radon or asbestos, inhaling toxic chemicals or minerals, or just being genetically predisposed to getting it. However, the upside is that nonsmokers do generally respond positively to the treatments given for their cancer.

Lung cancer is caused by certain cells in the body malfunctioning and dividing abnormally. These cells end up producing excessive tissue that turns into a tumor. There are non-small cell lung cancer and small cell lung cancer. Both types are treated differently.

So, how do you know if you may have lung cancer? Some signs include: labored breathing, wheezing, shortness of breath, excessive, persistent coughing, an increase in phlegm, a change in the phlegm's color or bloody phlegm, pain in the back, chest, or shoulder area, and swelling in the face and neck. If you have any of these signs, see a doctor immediately.

If you are a smoker, your chances of getting lung cancer are greatly reduced when you quit smoking. The American Cancer Society states that in the last 30 years, the cure rate for lung cancer has doubled.

While the stakes are higher for women smokers, quitting today will lower your chances of getting lung cancer. However, if you should still get lung cancer, quitting smoking would greatly increase your survival rate. Be aware of changes you can make in your lifestyle and environment to help keep yourself safe from this disease.

Popular posts from this blog

Lung cancer survival rate - Stage 2 lung cancer

When a person looks for a medical professional about the stage 2 lung cancer, one of the first questions that come to mind is: what is my lung cancer survival rate? This is largely influenced by the medical records showing that lung cancer is one of the lowest chances of survival of cancers in the world. One must realize that these statistics are only numbers and a variety of factors that can affect your chances of being cured. The lung cancer survival rate is affected by several variables. One such variable is age. Younger people tend to have a greater chance of survival for people over 50. This is due to the strong natural defenses younger than the older. Medical records also indicate that women with lung cancer in stage 2 have a greater ability to be cured of their male counterparts the parties. The spread of malignant tumor is a very important factor in determining the survival of lung cancer exchange rate. The tumors may spread from the lung tissu...

Who should get a CT scan to screen for lung cancer?

By Jenifer Goodwin HealthDay Reporter THURSDAY, June 30 (HealthDay News) -- Annual low-dose CT scans cut the death rate from lung cancer by 20% in heavy smokers and formerly heavy smokers, compared to those who get annual chest X-rays, according to the results of a major National Cancer Institute study released on Wednesday. Experts are calling the findings a major advance in efforts to combat lung cancer deaths. By catching the cancer early, the tumors can be removed surgically -- hopefully before they've spread and become very difficult to cure. "This is a momentous time in the history of public health research," said Dr. Otis Brawley, chief medical officer of the American Cancer Society. "The NLST [National Lung Screening Trial] is the best-designed and best-performed lung cancer screening study in history." Yet the findings raise as many questions as they answer, said Dr. Harold Sox, a professor emeritus of medicine at Dartmouth Medical School who wrote an...